Report an error

Spotted something inaccurate in “First Oral PCSK9 Inhibitor Enlicitide Achieves Significant Cholesterol Reduction”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.